Clinical Trial: A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight

U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07202884) titled 'A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight' on Sept. 24.

Brief Summary: The GZPS master protocol will support two independent studies, J2A-MC-GZS1 and J2A-MC-GZS2. Each study will see how well and safely orforglipron works in adult female participants with stress urinary incontinence (SUI) who have obesity or overweight. SUI is leaking urine during movement or activity such as coughing or exercising. Participation in the study will last about 58 weeks from screening to safety follow-up.

Study Start Date: Oct., 2025

Study Type: INTERVENTIONAL

Condition: Urinary In...